▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

NortonLifeLock Q3 21 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 2/4/2021 3:04 PM ET

NortonLifeLock Inc. (NLOK) will host a conference call at 5:00 PM ET on February 4, 2021, to discuss Q3 21 earnings results.

To access the live webcast, log on to http://Investor.NortonLifeLock.com

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In September

Biotech Stocks Facing FDA Decision In September

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Latest Updates on COVID-19

Covid Conditions Improving Nationally In US, Data Shows

FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways

Pfizer, BioNTech Apply For EUA In US Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Kids

Synairgen Reports Positive 60 And 90-day Long COVID Data From Phase 3 SNG001 Trial; Stock Up

U.S. Covid Cases Fall 29% In Last Fortnight

Read More

COVID-19: Drugs in Development

RELATED NEWS

NortonLifeLock Says Merger With Avast To Close On September 12

NortonLifeLock Inc. Q1 Profit Increases, beats estimates

NortonLifeLock Q1 23 Earnings Conference Call At 5:00 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways

Netflix Adding New Feature To Mobile Games

GM Delays Return-to-Office Plan After Employee Backlash

Ford Asks For New Trial After $1.7 Bln Jury Verdict In Truck Rollover Case

Macy's To Hire More Than 41,000 Seasonal Colleagues

SSP Group Sees Strong Recovery In Q4 Revenues, Lifts FY22 Outlook; Says Confident In FY23

Apple To Make IPhone 14 In India

AstraZeneca : Japan Approves Koselugo For Rare Genetic Disease In Paediatric Patients

Chase, DoorDash To Launch DoorDash Credit Card - Quick Facts

Neogen Q1 Net Profit Plunges, But Revenue Up 3%

Rational AG Raises FY22 Guidance

Valneva In Talks With Partner For Funding To Develop Potential Second-generation COVID-19 Vaccine

Seagen, LAVA Therapeutics Ink Worldwide License Agreement To Develop And Commercialize LAVA-1223

Netflix Adding New Feature To Mobile Games

Innocoll To Make $2 Mln Payment To DURECT On First Commercial Sale Of POSIMIR

Rackspace Technology Promotes CFO Amar Maletira To Succeed Kevin Jones As CEO

Leslie's Climbs 11% Ahead Of Addition To S&P SmallCap 600

ABB Inc. Invests $13 Mln In Iberville Site To Boost Production

Vendease Raises $30 Mln In Equity, Debt Funding

ILPT Appoint Donley As CFO

Ocular Therapeutix Reports Positive Interim Data From Phase 1 Trial Of OTX-TKI For Wet AMD

Everest : China Approves IND Application For Phase 1b Study Of EVER001 In Glomerular Diseases

Beauty Health Authorizes $200 Mln Share Buyback; Inks $100 Mln ASR Deal With JPMorgan

Rite Aid Q2 Adj. Loss Wider Than Estimates; Slashes FY23 Adj. Loss Outlook

Volkswagen Prices Porsche IPO At EUR 82.50/shr, High End Of Expected Range

Chevron, Mitsui Oil Exploration To Collaborate On Advanced Geothermal Technology

Balfour Beatty Fixed As Sole Contractor To Scape Civil Engineering Frameworks Worth 4 Bln Pounds

UroGen Pharma Announces Label Change For JELMYTO - Quick Facts

Emerson In Deal To Sell Russia Business To Local Management